-
公开(公告)号:US20210030676A1
公开(公告)日:2021-02-04
申请号:US16966626
申请日:2019-01-31
Applicant: Universität Basel , Universität Freiburg
Inventor: Bert MÜLLER , Andreas ZUMBÜHL , Thomas PFOHL , Dennis MÜLLER , Frederik NEUHAUS , Radu TANASESCU , Till SAXER , Marzia BUSCEMA , Sofiya MATVIYKIV , Gabriela GERGANOVA
Abstract: A liposome vesicle comprising a membrane consisting of 1,3-diheptadecanamidopropan-2-yl(2-(trimethylammonio)ethyl)phosphate surrounding a volume comprising a pharmaceutical drug or contrast agent. The vesicle is mechanosensitive at body temperature and at physiologically or pathophysiologically relevant shear stress.
-
公开(公告)号:US20200300872A1
公开(公告)日:2020-09-24
申请号:US16651992
申请日:2018-09-27
Applicant: UNIVERSITÄT BASEL
Inventor: Gilbert KOCH , Sven WELLMANN , Marc PFISTER , Severin KASSER , Melanie WILBAUX
Abstract: The invention relates to methods for estimating a bilirubin level of a neonate, comprising the steps of acquiring a series of bilirubin levels estimated at different time points from a sample obtained from a neonate; acquiring a plurality of covariates from the neonate, each comprising an information about a neonatal property; providing a pre-defined bilirubin model function; determining a plurality of model parameters of the bilirubin model function; and determining from the series of acquired bilirubin levels and the bilirubin model function with the determined model parameters an expected bilirubin level of the neonate for a time particularly later than a lastly acquired bilirubin level of the series of bilirubin levels.
-
公开(公告)号:US20200253590A1
公开(公告)日:2020-08-13
申请号:US16753784
申请日:2018-10-05
Applicant: UNIVERSITÄT BASEL , ARTIDIS AG
Inventor: Marija PLODINEC , Ludovit Pavel ZWEIFEL , Philipp Maximillian OERTLE , Armin STUMPP , Marko LOPARIC
Abstract: The invention relates to a core biopsy needle (1) for obtaining a tissue sample comprising a hollow outer needle (10) extending along a longitudinal axis (L), and an inner needle (20), which is at least partially arranged or arrangeable within said outer needle along said longitudinal axis (L), wherein said inner needle (20) comprises at least one tissue-holding surface (21), wherein said tissue-holding surface (21) is adapted such that a tissue (3) adheres to the at least one tissue-holding surface (21), when the core biopsy needle (1) is inserted into the tissue (3).
-
84.
公开(公告)号:US10564182B2
公开(公告)日:2020-02-18
申请号:US15119432
申请日:2015-02-17
Applicant: UNIVERSITÄT BASEL , ETH Zurich
Inventor: David Martinez-Martin , Daniel J. Mueller , Sascha Martin , Christoph Gerber , Benjamin Bircher
IPC: G01N29/02 , G01Q30/02 , G01N21/64 , G02B21/00 , G02B21/16 , G01N21/65 , G02B21/26 , B81B3/00 , G01G9/00 , G02B21/32
Abstract: The invention relates to a measuring device and a method for determining mass and/or mechanical properties of a biological system.
-
公开(公告)号:US10545169B2
公开(公告)日:2020-01-28
申请号:US15746717
申请日:2016-07-15
Applicant: Universität Basel , ETH Zurich
Inventor: David Martinez-Martin , Daniel J. Mueller , Sascha Martin , David Alsteens , Gotthold Flaschner
Abstract: The invention relates to a top-cover for a controlled environmental system (CES) for use with a measurement technique that requires introducing a probe to a sample placed on a sample holder, a CES and a procedure to control the environment for a sample in a system in particular a CES during a measurement with a probe based technique.
-
公开(公告)号:US20190284178A1
公开(公告)日:2019-09-19
申请号:US16301729
申请日:2017-05-17
Applicant: PIQUR THERAPEUTICS AG , UNIVERSITÄT BASEL
Inventor: Denise RAGEOT , Paul HEBEISEN , Florent BEAUFILS , Doriano FABBRO , Petra HILLMANN-WÜLLNER , Hoa Huu Phuc NGUYEN , Wolfgang LÖSCHER , Claudia BRANDT , Alexander Markus SELE
IPC: C07D413/14 , C07D451/02 , C07D417/14 , C07D451/14 , C07D498/08 , C07D519/00 , A61P25/08 , A61P25/28
Abstract: The present invention is relates to a compound of formula (I), wherein X1, X2 and X3 are, independently of each other, N or CH; with the proviso that at least two of X1, X2 and X3 are N; Y is N or CH; R1 and R2 are independently of each other (iii) a morpholinyl of formula (II) wherein the arrow denotes the bond in formula (I); and wherein R3 and R4 are independently of each other H, C1-C3alkyl optionally substituted with one or two OH, C1-C2fluoroalkyl, C1-C2alkoxy, C1-C2alkoxyC1-C3alkyl, CN, or C(O)O—C1-C2alkyl; or R3 and R4 form together a bivalent residue —R5R6— selected from C1-C3alkylene optionally substituted with 1 to 4 F, —CH2—O—CH2—, —CH2—NH—CH2—, or any of the structures wherein the arrows denote the bonds in formula (II); or (iv) a saturated 6-membered heterocyclic ring Z selected from thiomorpholinyl and piperazinyl, optionally substituted by 1 to 3 R7; wherein R7 is independently at each occurrence C1-C3alkyl optionally substituted with one or two OH, C1-C2fluoroalkyl, C1-C2alkoxyC1-C3alkyl, C3-C6cycloalkyl; or two R7 substituents form together a bivalent residue —R8R9— selected from C1-C3alkylene optionally substituted with 1 to 4 F, —CH2—O—CH2— or —O—CH2CH2—O—; with the proviso that at least one of R1 and R2 is a morpholinyl of formula II; and prodrugs, metabolites, tautomers, solvates and pharmaceutically acceptable salts thereof, for use in the prevention or treatment of a neurological disorder in a subject.
-
公开(公告)号:US20190015497A1
公开(公告)日:2019-01-17
申请号:US15773524
申请日:2016-11-17
Applicant: Universität Basel
Inventor: Simon Ittig , Marlise Amstutz , Christoph Kasper , Guy R. Cornelis
IPC: A61K39/02 , A61P35/00 , A61K39/00 , C12N15/74 , A61K39/104 , A61K39/112
Abstract: The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.
-
公开(公告)号:US20180224479A1
公开(公告)日:2018-08-09
申请号:US15746717
申请日:2016-07-15
Applicant: Universität Basel , ETH Zurich
Inventor: David Martinez-Martin , Daniel J. Mueller , Sascha Martin , David Alsteens , Gotthold Fläschner
Abstract: The invention relates to a top-cover for a controlled environmental system (CES) for use with a measurement technique that requires introducing a probe to a sample placed on a sample holder, a CES and a procedure to control the environment for a sample in a system in particular a CES during a measurement with a probe based technique.
-
公开(公告)号:US11802927B2
公开(公告)日:2023-10-31
申请号:US17687392
申请日:2022-03-04
Applicant: Cornell University , Universität Basel
Inventor: Reza Rahmanzadeh , Cristina Granziera , Yi Wang , Riccardo Galbusera
IPC: G01R33/565 , A61B5/055 , G01R33/56 , G01R33/50
CPC classification number: G01R33/56536 , A61B5/055 , G01R33/50 , G01R33/5608
Abstract: Quantitative susceptibility mapping methods, systems and computer-accessible medium include generating images of tissue magnetism property from complex magnetic resonance imaging data using the Bayesian inference approach. The tissue magnetism images is then used to monitor remyelination, such as remyelination in multiple sclerosis patients in response to therapy. Multiple sclerosis lesions defined on magnetic resonance imaging are further characterized on tissue magnetism images into hyperintense, isointense and hypointense parts for measuring remyelination. Thus, magnetic susceptibility information and other tissue properties associated with at least one structure are determined.
-
公开(公告)号:US11656234B2
公开(公告)日:2023-05-23
申请号:US16651992
申请日:2018-09-27
Applicant: UNIVERSITÄT BASEL
Inventor: Gilbert Koch , Sven Wellmann , Marc Pfister , Severin Kasser , Melanie Wilbaux
CPC classification number: G01N33/728 , G06F17/18 , G16H10/00 , G16H50/20 , Y10T436/146666
Abstract: The invention relates to a method and a computer program for estimating a bilirubin level of a neonate, composed of the steps of:
Acquiring a series of bilirubin levels estimated at different time points from a sample obtained from a neonate,
Acquiring a plurality of covariates from the neonate, each composed of an information about a neonatal property,
Providing a pre-defined bilirubin model function, wherein the bilirubin model function is configured to describe a time course of a bilirubin level of a neonate,
Determining a plurality of model parameters of the bilirubin model function, wherein each model parameter is estimated from at least one covariate of the plurality of covariates and an associated population model parameter,
Determining from the series of acquired bilirubin levels and the bilirubin model function with the determined model parameters an expected bilirubin level of the neonate for a time particularly later than a lastly acquired bilirubin level of the series of bilirubin levels.
-
-
-
-
-
-
-
-
-